Page last updated: 2024-08-26

eudragit rs and Inflammation

eudragit rs has been researched along with Inflammation in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Atefi Khah, M; Dehghani, MA; Khorsandi, L; Mahdavinia, M; Moghimipour, E; Shakiba Maram, N1
Katara, R; Majumdar, DK; Sachdeva, S1
Adedokun, MO; Attama, AA; Kenechukwu, FC; Momoh, MA; Odo, CE1
Das, MK; Deka, A; Kalita, B; Sarma, M1
Katara, R; Majumdar, DK1
Ertan, G; Güneri, T; Ozcan, I; Ozgüney, I1

Other Studies

6 other study(ies) available for eudragit rs and Inflammation

ArticleYear
Protective effect of gallic acid and gallic acid-loaded Eudragit-RS 100 nanoparticles on cisplatin-induced mitochondrial dysfunction and inflammation in rat kidney.
    Biochimica et biophysica acta. Molecular basis of disease, 2020, 12-01, Volume: 1866, Issue:12

    Topics: Acrylic Resins; Administration, Oral; Animals; Cisplatin; Dose-Response Relationship, Drug; Gallic Acid; Inflammation; Injections, Intraperitoneal; Kidney Diseases; Male; Mitochondria; Nanoparticles; Oxidative Stress; Protective Agents; Rats; Rats, Wistar

2020
Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
    Pharmaceutical development and technology, 2019, Volume: 24, Issue:3

    Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Chemistry, Pharmaceutical; Crystallization; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Eye Diseases; Inflammation; Nanoparticles; Neutrophils; Particle Size; Rabbits

2019
Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres.
    Drug delivery, 2014, Volume: 21, Issue:3

    Topics: Acrylic Resins; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Drug Carriers; Female; Hydrogen-Ion Concentration; Inflammation; Male; Microspheres; Particle Size; Rats, Wistar; Solubility; Technology, Pharmaceutical

2014
Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
    AAPS PharmSciTech, 2017, Volume: 18, Issue:3

    Topics: Acrylic Resins; Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Carrageenan; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Edema; Inflammation; Male; Permeability; Phospholipids; Polyethylene Glycols; Polymers; Rabbits; Rats; Rats, Wistar; Resveratrol; Skin; Skin Absorption; Stilbenes; Transdermal Patch

2017
Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Colloids and surfaces. B, Biointerfaces, 2013, Mar-01, Volume: 103

    Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Arachidonic Acid; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cornea; Diclofenac; Drug Delivery Systems; Drug Stability; Eye; Goats; Inflammation; Nanoparticles; Particle Size; Permeability; Polymers; Rabbits; Solutions; Spectroscopy, Fourier Transform Infrared; Static Electricity; Surface Properties; Suspensions; X-Ray Diffraction

2013
The preparation and evaluation of sustained release suppositories containing ketoprofen and Eudragit RL 100 by using factorial design.
    Pharmaceutical development and technology, 2007, Volume: 12, Issue:1

    Topics: Acrylic Resins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Carrageenan; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Delayed-Action Preparations; Diffusion; Drug Compounding; Excipients; Inflammation; Ketoprofen; Kinetics; Male; Octanols; Rats; Solubility; Suppositories; Water

2007